Copyright Reports & Markets. All rights reserved.

Global Infection and Infection POCT Testing Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Infection and Infection POCT Testing by Type
    • 1.3.1 Overview: Global Infection and Infection POCT Testing Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Infection and Infection POCT Testing Consumption Value Market Share by Type in 2025
    • 1.3.3 Equipment
    • 1.3.4 Test Kit
    • 1.3.5 Other
  • 1.4 Global Infection and Infection POCT Testing Market by Application
    • 1.4.1 Overview: Global Infection and Infection POCT Testing Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Other
  • 1.5 Global Infection and Infection POCT Testing Market Size & Forecast
  • 1.6 Global Infection and Infection POCT Testing Market Size and Forecast by Region
    • 1.6.1 Global Infection and Infection POCT Testing Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Infection and Infection POCT Testing Market Size by Region, (2021-2032)
    • 1.6.3 North America Infection and Infection POCT Testing Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Infection and Infection POCT Testing Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Infection and Infection POCT Testing Market Size and Prospect (2021-2032)
    • 1.6.6 South America Infection and Infection POCT Testing Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Infection and Infection POCT Testing Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 SERION Immunologics
    • 2.1.1 SERION Immunologics Details
    • 2.1.2 SERION Immunologics Major Business
    • 2.1.3 SERION Immunologics Infection and Infection POCT Testing Product and Solutions
    • 2.1.4 SERION Immunologics Infection and Infection POCT Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 SERION Immunologics Recent Developments and Future Plans
  • 2.2 SD BIOSENSOR
    • 2.2.1 SD BIOSENSOR Details
    • 2.2.2 SD BIOSENSOR Major Business
    • 2.2.3 SD BIOSENSOR Infection and Infection POCT Testing Product and Solutions
    • 2.2.4 SD BIOSENSOR Infection and Infection POCT Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 SD BIOSENSOR Recent Developments and Future Plans
  • 2.3 Bio-Rad Laboratories
    • 2.3.1 Bio-Rad Laboratories Details
    • 2.3.2 Bio-Rad Laboratories Major Business
    • 2.3.3 Bio-Rad Laboratories Infection and Infection POCT Testing Product and Solutions
    • 2.3.4 Bio-Rad Laboratories Infection and Infection POCT Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Bio-Rad Laboratories Recent Developments and Future Plans
  • 2.4 Thermo Fisher Scientific
    • 2.4.1 Thermo Fisher Scientific Details
    • 2.4.2 Thermo Fisher Scientific Major Business
    • 2.4.3 Thermo Fisher Scientific Infection and Infection POCT Testing Product and Solutions
    • 2.4.4 Thermo Fisher Scientific Infection and Infection POCT Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.5 Abbott Laboratories
    • 2.5.1 Abbott Laboratories Details
    • 2.5.2 Abbott Laboratories Major Business
    • 2.5.3 Abbott Laboratories Infection and Infection POCT Testing Product and Solutions
    • 2.5.4 Abbott Laboratories Infection and Infection POCT Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Abbott Laboratories Recent Developments and Future Plans
  • 2.6 Roche Diagnostics
    • 2.6.1 Roche Diagnostics Details
    • 2.6.2 Roche Diagnostics Major Business
    • 2.6.3 Roche Diagnostics Infection and Infection POCT Testing Product and Solutions
    • 2.6.4 Roche Diagnostics Infection and Infection POCT Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Roche Diagnostics Recent Developments and Future Plans
  • 2.7 BioMerieux
    • 2.7.1 BioMerieux Details
    • 2.7.2 BioMerieux Major Business
    • 2.7.3 BioMerieux Infection and Infection POCT Testing Product and Solutions
    • 2.7.4 BioMerieux Infection and Infection POCT Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 BioMerieux Recent Developments and Future Plans
  • 2.8 PerkinElmer
    • 2.8.1 PerkinElmer Details
    • 2.8.2 PerkinElmer Major Business
    • 2.8.3 PerkinElmer Infection and Infection POCT Testing Product and Solutions
    • 2.8.4 PerkinElmer Infection and Infection POCT Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 PerkinElmer Recent Developments and Future Plans
  • 2.9 Enzo Life Sciences
    • 2.9.1 Enzo Life Sciences Details
    • 2.9.2 Enzo Life Sciences Major Business
    • 2.9.3 Enzo Life Sciences Infection and Infection POCT Testing Product and Solutions
    • 2.9.4 Enzo Life Sciences Infection and Infection POCT Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Enzo Life Sciences Recent Developments and Future Plans
  • 2.10 Abcam
    • 2.10.1 Abcam Details
    • 2.10.2 Abcam Major Business
    • 2.10.3 Abcam Infection and Infection POCT Testing Product and Solutions
    • 2.10.4 Abcam Infection and Infection POCT Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Abcam Recent Developments and Future Plans
  • 2.11 DRG International
    • 2.11.1 DRG International Details
    • 2.11.2 DRG International Major Business
    • 2.11.3 DRG International Infection and Infection POCT Testing Product and Solutions
    • 2.11.4 DRG International Infection and Infection POCT Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 DRG International Recent Developments and Future Plans
  • 2.12 Creative Diagnostics
    • 2.12.1 Creative Diagnostics Details
    • 2.12.2 Creative Diagnostics Major Business
    • 2.12.3 Creative Diagnostics Infection and Infection POCT Testing Product and Solutions
    • 2.12.4 Creative Diagnostics Infection and Infection POCT Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Creative Diagnostics Recent Developments and Future Plans
  • 2.13 Beyotime
    • 2.13.1 Beyotime Details
    • 2.13.2 Beyotime Major Business
    • 2.13.3 Beyotime Infection and Infection POCT Testing Product and Solutions
    • 2.13.4 Beyotime Infection and Infection POCT Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Beyotime Recent Developments and Future Plans
  • 2.14 GenScript
    • 2.14.1 GenScript Details
    • 2.14.2 GenScript Major Business
    • 2.14.3 GenScript Infection and Infection POCT Testing Product and Solutions
    • 2.14.4 GenScript Infection and Infection POCT Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 GenScript Recent Developments and Future Plans
  • 2.15 Kehua Biotech
    • 2.15.1 Kehua Biotech Details
    • 2.15.2 Kehua Biotech Major Business
    • 2.15.3 Kehua Biotech Infection and Infection POCT Testing Product and Solutions
    • 2.15.4 Kehua Biotech Infection and Infection POCT Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Kehua Biotech Recent Developments and Future Plans
  • 2.16 Mindray Medical
    • 2.16.1 Mindray Medical Details
    • 2.16.2 Mindray Medical Major Business
    • 2.16.3 Mindray Medical Infection and Infection POCT Testing Product and Solutions
    • 2.16.4 Mindray Medical Infection and Infection POCT Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Mindray Medical Recent Developments and Future Plans
  • 2.17 Antu Biotech
    • 2.17.1 Antu Biotech Details
    • 2.17.2 Antu Biotech Major Business
    • 2.17.3 Antu Biotech Infection and Infection POCT Testing Product and Solutions
    • 2.17.4 Antu Biotech Infection and Infection POCT Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Antu Biotech Recent Developments and Future Plans
  • 2.18 BD
    • 2.18.1 BD Details
    • 2.18.2 BD Major Business
    • 2.18.3 BD Infection and Infection POCT Testing Product and Solutions
    • 2.18.4 BD Infection and Infection POCT Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 BD Recent Developments and Future Plans
  • 2.19 Siemens
    • 2.19.1 Siemens Details
    • 2.19.2 Siemens Major Business
    • 2.19.3 Siemens Infection and Infection POCT Testing Product and Solutions
    • 2.19.4 Siemens Infection and Infection POCT Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Siemens Recent Developments and Future Plans
  • 2.20 Qiagen
    • 2.20.1 Qiagen Details
    • 2.20.2 Qiagen Major Business
    • 2.20.3 Qiagen Infection and Infection POCT Testing Product and Solutions
    • 2.20.4 Qiagen Infection and Infection POCT Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 Qiagen Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Infection and Infection POCT Testing Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Infection and Infection POCT Testing by Company Revenue
    • 3.2.2 Top 3 Infection and Infection POCT Testing Players Market Share in 2025
    • 3.2.3 Top 6 Infection and Infection POCT Testing Players Market Share in 2025
  • 3.3 Infection and Infection POCT Testing Market: Overall Company Footprint Analysis
    • 3.3.1 Infection and Infection POCT Testing Market: Region Footprint
    • 3.3.2 Infection and Infection POCT Testing Market: Company Product Type Footprint
    • 3.3.3 Infection and Infection POCT Testing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Infection and Infection POCT Testing Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Infection and Infection POCT Testing Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Infection and Infection POCT Testing Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Infection and Infection POCT Testing Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Infection and Infection POCT Testing Consumption Value by Type (2021-2032)
  • 6.2 North America Infection and Infection POCT Testing Market Size by Application (2021-2032)
  • 6.3 North America Infection and Infection POCT Testing Market Size by Country
    • 6.3.1 North America Infection and Infection POCT Testing Consumption Value by Country (2021-2032)
    • 6.3.2 United States Infection and Infection POCT Testing Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Infection and Infection POCT Testing Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Infection and Infection POCT Testing Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Infection and Infection POCT Testing Consumption Value by Type (2021-2032)
  • 7.2 Europe Infection and Infection POCT Testing Consumption Value by Application (2021-2032)
  • 7.3 Europe Infection and Infection POCT Testing Market Size by Country
    • 7.3.1 Europe Infection and Infection POCT Testing Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Infection and Infection POCT Testing Market Size and Forecast (2021-2032)
    • 7.3.3 France Infection and Infection POCT Testing Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Infection and Infection POCT Testing Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Infection and Infection POCT Testing Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Infection and Infection POCT Testing Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Infection and Infection POCT Testing Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Infection and Infection POCT Testing Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Infection and Infection POCT Testing Market Size by Region
    • 8.3.1 Asia-Pacific Infection and Infection POCT Testing Consumption Value by Region (2021-2032)
    • 8.3.2 China Infection and Infection POCT Testing Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Infection and Infection POCT Testing Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Infection and Infection POCT Testing Market Size and Forecast (2021-2032)
    • 8.3.5 India Infection and Infection POCT Testing Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Infection and Infection POCT Testing Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Infection and Infection POCT Testing Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Infection and Infection POCT Testing Consumption Value by Type (2021-2032)
  • 9.2 South America Infection and Infection POCT Testing Consumption Value by Application (2021-2032)
  • 9.3 South America Infection and Infection POCT Testing Market Size by Country
    • 9.3.1 South America Infection and Infection POCT Testing Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Infection and Infection POCT Testing Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Infection and Infection POCT Testing Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Infection and Infection POCT Testing Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Infection and Infection POCT Testing Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Infection and Infection POCT Testing Market Size by Country
    • 10.3.1 Middle East & Africa Infection and Infection POCT Testing Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Infection and Infection POCT Testing Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Infection and Infection POCT Testing Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Infection and Infection POCT Testing Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Infection and Infection POCT Testing Market Drivers
  • 11.2 Infection and Infection POCT Testing Market Restraints
  • 11.3 Infection and Infection POCT Testing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Infection and Infection POCT Testing Industry Chain
  • 12.2 Infection and Infection POCT Testing Upstream Analysis
  • 12.3 Infection and Infection POCT Testing Midstream Analysis
  • 12.4 Infection and Infection POCT Testing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Infection and Infection POCT Testing market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Infectious and infectious POCT (Point-of-Care Testing) tests are rapid diagnostic tests performed at the point of patient care. POCT testing devices and kits are designed to provide test results quickly without the need for complex laboratory facilities, usually within minutes to hours. This is critical for rapid diagnosis and timely treatment of infectious diseases and infections.
    This report is a detailed and comprehensive analysis for global Infection and Infection POCT Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Infection and Infection POCT Testing market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Infection and Infection POCT Testing market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Infection and Infection POCT Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Infection and Infection POCT Testing market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Infection and Infection POCT Testing
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Infection and Infection POCT Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include SERION Immunologics, SD BIOSENSOR, Bio-Rad Laboratories, Thermo Fisher Scientific, Abbott Laboratories, Roche Diagnostics, BioMerieux, PerkinElmer, Enzo Life Sciences, Abcam, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Infection and Infection POCT Testing market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Equipment
    Test Kit
    Other
    Market segment by Application
    Hospital
    Clinic
    Other
    Market segment by players, this report covers
    SERION Immunologics
    SD BIOSENSOR
    Bio-Rad Laboratories
    Thermo Fisher Scientific
    Abbott Laboratories
    Roche Diagnostics
    BioMerieux
    PerkinElmer
    Enzo Life Sciences
    Abcam
    DRG International
    Creative Diagnostics
    Beyotime
    GenScript
    Kehua Biotech
    Mindray Medical
    Antu Biotech
    BD
    Siemens
    Qiagen
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Infection and Infection POCT Testing product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Infection and Infection POCT Testing, with revenue, gross margin, and global market share of Infection and Infection POCT Testing from 2021 to 2026.
    Chapter 3, the Infection and Infection POCT Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Infection and Infection POCT Testing market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Infection and Infection POCT Testing.
    Chapter 13, to describe Infection and Infection POCT Testing research findings and conclusion.

    Buy now